Cargando…
The aqueous root extract of Withania somnifera ameliorates LPS-induced inflammatory changes in the in vitro cell-based and mice models of inflammation
Introduction: Most critically ill COVID-19 patients have bronchitis, pneumonia, and acute respiratory distress syndrome (ARDS) due to excessive inflammatory conditions. Corticosteroids have largely been prescribed for the management of inflammation in these patients. However, long-term use of cortic...
Autores principales: | Sharma, Phulwanti Kumari, Kumar, Lokesh, Goswami, Yamini, Pujani, Mukta, Dikshit, Madhu, Tandon, Ruchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291246/ https://www.ncbi.nlm.nih.gov/pubmed/37377934 http://dx.doi.org/10.3389/fphar.2023.1139654 |
Ejemplares similares
-
Ameliorating effect of Withania somnifera root extract in Escherichia coli–infected broilers
por: Kumari, Mamta, et al.
Publicado: (2020) -
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
por: Kasarla, Siva Swapna, et al.
Publicado: (2022) -
The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases
por: Alanazi, Hamad H., et al.
Publicado: (2023) -
In vitro antibacterial effect of Withania somnifera root extract on Escherichia coli
por: Kumari, Mamta, et al.
Publicado: (2015) -
Withania Coagulans and Somnifera
por: Verghese, M.
Publicado: (1885)